The M4M5 Cytoplasmic Loop of the Na,K-ATPase, Overexpressed in Escherichia coli, Binds Nucleoside Triphosphates with the Same Selectivity as the Intact Native Protein*

Craig Gatto, April X. Wang, and Jack H. KaplanDagger

From the Department of Biochemistry and Molecular Biology, Oregon Health Sciences University, Portland, Oregon 97201-3098

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Escherichia coli was used to overexpress the large cytoplasmic loop of the rat Na,K-ATPase. A 1260-base DNA segment encoding Lys354-Lys774 of the rat alpha 1-subunit was constructed via polymerase chain reaction. The polymerase chain reaction product was successfully subcloned into the expression vector pET-28 (Novagen), which produces an N-terminal 6-histidine-tagged fusion protein. The pET-28 vector containing rat alpha -loop, i.e. pAN, was used to transform calcium-competent E. coli BL21(DE3) cells, and positive clones were selected by kanamycin resistance. Bacterial cultures were grown, and protein synthesis was induced with isopropyl beta -D-thiogalactoside. Cells were harvested and lysed, revealing production of the His-tagged fusion protein (~46 kDa). The fusion protein was affinity-purified from other soluble cellular proteins via a Ni-NTA column, which routinely yielded ~20 mg of soluble His6-alpha -loop/L cell culture. The His6-alpha -loop retained significant native structure, as evidenced by the ability of ATP and ADP (but not AMP, CTP, GTP, or UTP) to protect against chemical modification by either fluorescein isothiocyanate or maleimidylanilinonapthalene sulfonic acid. More specifically, circular dichroism spectroscopy was used to estimate the secondary structure of the His6 loop, revealing an ordered folding composed of 23% alpha -helix, 23% antiparallel beta -sheet, 4% parallel beta -sheet, 19% beta -turn, and 32% random coil. The 6-histidine loop bound the fluorescent ATP analog trinitrophenyl-ATP with high affinity, as determined by measuring the fluorescence changes associated with binding. Affinities for ATP (~350 µM) and ADP (~550 µM) were determined by their ability to compete with and displace 2',3'-O-[2,4,6,-trinitrophenyl]-ATP. These nucleotide affinities are similar to those observed for the E2 conformation of the intact Na,K-ATPase.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The Na,K-ATPase (3.6.1.37) is an integral membrane protein that is responsible for maintaining ionic homeostasis in animal cells by mediating the active translocation of sodium and potassium ions against their electrochemical gradients across the plasma membrane. The ion gradients produced by the sodium pump are important for cell excitability and contractility, as well as for regulation of other intracellular ion and solute concentrations. The current model for the sodium pump cycle is conserved for other ion pumps, e.g. the plasma membrane and sarcoplasmic reticulum calcium pumps, the gastric hydrogen/potassium pump, and the Neurospora proton pump. These ion pumps make up the enzyme class known as the P-type ATPases. Although much information has been gathered about the kinetic mechanism of the sodium pump, there is still rather little detail known about the structure of the protein.

The sodium pump exists as a functional heterodimeric protein consisting of a catalytic alpha -subunit (~110 kDa) and a smaller, glycosylated beta -subunit (~55 kDa). Both subunits have been cloned, and the primary structure has been determined in several isoforms from a variety of species (1). However, even after extensive study for several decades, information about the specific amino acids involved in formation of the binding sites for physiological ligands is rudimentary. Although the detailed topology of the alpha -subunit of the sodium pump is still the subject of investigation, an overall consensus on structure is emerging; it shows 10 transmembrane segments (3). All the residues implicated with ATP binding thus far have been localized to the major cytoplasmic loop, which is composed of about 430 amino acid residues between transmembrane segments M4 and M5 (2). Moreover, this loop contains four of the most highly conserved P-type ATPase sequences (3). Much of the information suggesting the involvement of various amino acid residues with pump function comes from chemical modification experiments. Such studies have identified a number of residues in the M4M5 loop thought to be involved in ATP binding. For example, Lys480, Lys501, Gly502, Asp710, Asp714 and Lys719 are all modified by a variety of chemical agents in the absence of ATP but not in its presence, suggesting a role in ATP binding (4). In subsequent studies, some of these residues were changed via mutagenesis with little or no effect on enzyme activity (1). However, measurements of overall enzyme activity only provide information on whether the mutated residue is absolutely essential for function, but they do not necessarily address whether the residue is involved directly in ATP binding. For example, mutation of Asp369 (i.e. the site of phosphorylation), not surprisingly, abolishes enzyme activity (5), but interestingly, mutation of this residue increases the ATP binding affinity (6). Consequently, to determine whether a residue is important for ATP binding one must directly measure ATP binding and characterize its affinity. The only approach that will identify ATP contact residues is to crystallize the protein in the presence of substrate. Unfortunately, crystallographic analysis of integral membrane proteins still remains difficult because generally applicable strategies for obtaining x-ray quality crystals of these molecules do not yet exist.

As an approach to achieving this aim, we describe the bacterial production and purification of a soluble polypeptide corresponding to the large cytoplasmic loop of the Na,K-ATPase. This soluble protein is able to bind ATP, as evidenced by the ability of ATP to prevent modification by both fluorescein 5'-isothiocyanate (FITC)1 and 2-[4'maleimidylanilino]napthalene-6-sulfonic acid (MIANS), two fluorescent probes previously demonstrated to label the M4M5 loop of the full-length Na,K-ATPase in an ATP-protectable fashion. In addition, we used 2',3'-O-[2,4,6,-trinitrophenyl]adenosine 5'-triphosphate (TNP-ATP) fluorescence to estimate, by competition with ATP, the ATP binding affinity to this segment of the sodium pump. A preliminary report of some of this work was presented at the Eighth International Meeting on the sodium pump (7).

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Reagents, Media, and Bacterial Strains-- NaCl, ATP, ADP, AMP, CTP, GTP, UTP, ethanol, ethidium bromide, bovine serum albumin, ultrapure urea, 5-bromo-4-chloro-3-indolyl beta -D-galactopyranoside, and Tris base were purchased from Sigma. beta -mercaptoethanol, SDS, ammonium persulfate, Coomassie Brilliant Blue R-250, DNA miniprep kit, and low molecular weight standards were from Bio-Rad. 4-(2-Aminoethyl)-benzenesulfonyl fluoride hydrochloride was from ICN. Acrylamide and bisacrylamide were from Boehringer Mannheim. Rainbow gel electrophoresis standards were from Amersham Pharmacia Biotech. FITC, MIANS, and TNP-ATP were from Molecular Probes. Polyvinylidene difluoride electroblotting membrane was from Millipore. Tryptone, granulated agar, and yeast extract were from Difco. Agarose and restriction endonucleases were from Life Technologies, Inc. The pCR-Script cloning kit and Pfu DNA polymerase were from Stratagene. The pET-28 expression vector and Escherichia coli BL21(DE3) cells were from Novagen. Ampicillin and kanamycin were obtained from the University Hospital Pharmacy (Oregon Health Sciences University). E. coli DH5alpha cells were a generous gift from Dr. Linda Kenney (Molecular Microbiology and Immunology, Oregon Health Sciences University). DNA miniprep kits, DNA gel extraction kits, IPTG, and His6 antibody were from Qiagen. DNA sequencing was perfomed at the core facility at Oregon Health Sciences University.

Construction of the Protein Expression Vector pAN-- The portion of the rat alpha 1-subunit encoding the M4M5 cytoplasmic loop (Lys354-Lys774) was amplified via polymerase chain reaction (PCR) in the presence of 10 µM oligonucleotide primers (shown below), 1.2 mM of the four deoxynucleoside triphosphates, and 5 units of Pfu DNA polymerase in 50 µl of the manufacturer's buffer. The template was pGEM-ratalpha 1, a generous gift from Dr. Robert Mercer (Washington University, St. Louis, MO). Twenty-five PCR cycles (30 s at 94 °C, 1 min at 53 °C, and 2 min at 72 °C) were performed in a PTC-100 thermal cycler (MJ Research Inc.). Agarose gel electrophoresis of the PCR revealed a single DNA fragment of 1.2 kilobases.

The forward primer was as follows.
<AR><R><C><UP>5′-GC ATG </UP></C></R><R><C></C></R></AR><AR><R><C><UNL><UP>CAT ATG</UP></UNL></C></R><R><C>Nde<UP>I</UP></C></R></AR><AR><R><C><UP> <B>AAG AAC TGC CTG G</B></UP></C></R><R><C><UP>rat &agr;1 loop</UP></C></R></AR><AR><R><C><UP>-3′</UP></C></R><R><C></C></R></AR>

The reverse primer was as follows.
<AR><R><C><UP>5′-GG GTG TAA </UP></C></R><R><C></C></R></AR><AR><R><C><UNL><UP>GAA TT</UP></UNL></C></R><R><C><IT>Eco</IT><UP>RI</UP></C></R></AR><AR><R><C><UNL><UNL><UP>C TA</UP></UNL></UNL></C></R><R><C><UP>Stop</UP></C></R></AR><AR><R><C><UP><B>T TTC TTC AAG TTA TC</B></UP></C></R><R><C><UP>rat &agr;1 loop</UP></C></R></AR><AR><R><C><UP>-3′</UP></C></R><R><C></C></R></AR>

After gel purification of the PCR product, a blunt end ligation was performed with the SrfI-digested pCR-Script plasmid according to the manufacturer's protocol (Stratagene) (Fig. 1). (pCR-Script confers ampicillin resistance and contains a portion of the lacZ gene encoding the beta -galactosidase gene product providing blue-white color selection of recombinant plasmids.) Calcium competent (8) E. coli DH5alpha cells were transformed with the ligation mixture, and positive colonies were selected on LBamp agar plates containing 5-bromo-4-chloro-3-indolyl beta -D-galactopyranoside and IPTG. White colonies were selected and grown overnight in LBamp, and the DNA was isolated via minipreparation techniques (Bio-Rad and Qiagen DNA miniprep kits). Restriction endonuclease mapping revealed positive clones, which were subsequently sequenced to verify that no random mutations occurred during the PCR. The cloned M4M5 loop was released from pCR-Script by digesting with NdeI and EcoRI; these unique restriction sites were engineered into the oligonucleotide primers (see above). The 6-histidine fusion protein vector, pET-28 (Novagen), was also digested with EcoRI and NdeI. A ligation reaction was performed after gel purifying both DNA fragments at a ratio of 10:1 (insert to vector) using T4 DNA ligase (1 unit/10 ng of DNA) at 25 °C for 1 h. The cloned product, called pAN, was subsequently transformed into competent DH5alpha cells and selected by the kanamycin resistance conferred by pET-28. DH5alpha cells have a higher efficiency for transformation with ligation reactions than do BL21 cells. Therefore, we used DH5alpha cells for initial transformations and long term storage of vectors as glycerol stocks, whereas we preferred BL21(DE3) cells for protein expression.

Overexpression of a 6-Histidine-tagged M4M5 Loop-- The constructed pAN expression vector was used to transform calcium competent BL21 (DE3) cells. The E. coli transformants were selected on LBkan (30 µg/ml) agar plates. A single colony was picked to grow overnight in 5 ml of LBkan, and this culture was subsequently used to inoculate 1 liter of LBkan containing a final concentration of 2% ethanol. After the culture grew to an A600 of 0.8-1.0, 1 mM IPTG was added to induce the synthesis of protein from the lac promoter and grown further at 25 °C to an A of ~2.0.

Cells were then collected and suspended in 30 ml of a lysis buffer containing 50 mM Tris, 100 mM NaCl, pH 8.0, with a hand-held homogenizer. A 10-mg quantity of lysozyme was added in the presence of 150 µM 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride (serine protease inhibitor), and the mixture was incubated on ice for 30 min, with occasional plunging of the homogenizer. After addition of 40 mg of deoxycholic acid, the suspension was heated to 37 °C with constant stirring. Once the suspension became viscous and difficult to stir, 200 µl of deoxyribonuclease (1 mg/ml) was added, and the mixture was incubated at 25 °C until the suspension was no longer viscous (~30 min). A final concentration of 1% Triton X-100 was added, and the cell lysate was incubated for an additional 30 min at 25 °C. The soluble fraction was separated from the membranous fractions by centrifugation at 12,000 × g for 45 min at 4 °C. Expression of the His6 loop was verified by running a sample of the soluble cell lysate on a 10% Laemmli gel and electroblotting onto polyvinylidene difluoride membrane (10 mM CAPS, pH 11.0, 45 min). The polyvinylidene difluoride membrane was screened with a 1:1000 dilution of a 6-histidine antibody (Qiagen) revealing a protein (~46 kDa) from the lysate of IPTG-induced cells only.

Purification of His6 Loop via Ni2+-Column Chromatography-- A 4-ml slurry of His-Bind resin (nitriloacetic acid-agarose, Novagen) was placed into a 5-ml column; after the resin settled, a bed volume of 2 ml remained. The column was washed with 10 bed volumes of sterile deionized H2O and then charged with nickel by adding 5 bed volumes of 50 mM NiSO4. Unbound Ni2+ was washed away with 5 bed volumes of binding buffer (5 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 7.9). One-third of the soluble cell lysate (~10 ml) was applied to the Ni2+-column. The column was subsequently washed with 5 bed volumes of binding buffer to remove nonspecifically bound E. coli proteins. The desired His6 loop protein was eluted from the Ni2+-column with a linear imidazole gradient from 50 to 400 mM in a buffer containing 500 mM NaCl and 20 mM Tris (pH 7.9). Twenty-five 1.5-ml fractions were collected (0.5-0.75 ml/min flow rate, gravity flow) over 45-60 min and analyzed for protein content by the method of Bradford (9). Protein-containing fractions were further analyzed via SDS-polyacrylamide gel electrophoresis (i.e. 10% Laemmli gel). The desired product was routinely recovered over 5-6 fractions ranging from ~125 to 250 mM imidazole. The purity varied slightly between preparations; only preparations that were >= 95% pure (based upon densitometry of the Coomassie-stained peptide bands) were used for experimental measurements.

FITC and MIANS Modification Experiments-- An aliquot (10-20 µg) of the purified dog kidney Na,K-ATPase or the bacterially produced His6 loop was incubated with either 5 µM FITC or 50 µM MIANS for 10 min at 25 °C in 20 µl of a buffer containing 50 mM Tris (pH 7.4), 2 mM EDTA, and 5 mM of either ATP, ADP, AMP, CTP, GTP, or UTP as indicated in the corresponding figure (Fig. 3, A and B). For experiments testing whether FITC or MIANS could label denatured protein, the protein was incubated in the presence of 1% SDS prior to the chemical treatment. The chemical modification reactions were stopped by the addition of 40 µl of Laemmli sample buffer containing (at a 1:1:1 ratio) 10% SDS, 8 M urea, and 0.1 M Tris (pH 8.8) and a 5% final concentration of beta -mercaptoethanol. The entire 60-µl sample volume was loaded and run on a 12% SDS-polyacrylamide gel according to the method of Laemmli (10). FITC-labeled bands were visualized under UV illumination (366 nm), and then proteins were fixed and stained with 0.1% Coomassie Brilliant Blue R-250 in 10% acetic acid.

TNP-ATP Binding to Isolated His6 Loop and Competition by Adenine Nucleotides-- TNP-ATP binding to the His6 loop was performed essentially as described by Moczydlowski and Fortes (18) for TNP-ATP binding to Na,K-ATPase with minor changes. Briefly, fluorescence changes were measured in quartz cuvettes on a model PTI-QM1 (Photon Technology International, Monmouth Junction, NJ) steady state fluorometer. The excitation wavelength was 410 nm (5 nm width), and the emission wavelength was 545 nm (2 nm width). Aliquots of a 1 mM TNP-ATP stock solution were titrated into a 1-ml solution of 50 mM MOPS (pH 7.5) containing 100 µg of His6 loop maintained at 25 °C. The same TNP-ATP additions were made into buffer only. The difference between the protein-containing and protein-free solution revealed the fluorescence increases due to interactions between TNP-ATP and the His6 loop.

Competition with nucleotides was measured by titrating aliquots from a 25 mM stock of ATP, ADP, or AMP into a 1-ml solution of 50 mM MOPS (pH 7.5) containing 1 µM TNP-ATP and 10 µM His6 loop. The high protein to TNP-ATP ratio was to ensure that essentially all of the TNP-ATP was bound prior to the nucleotide additions. If there is a significant portion of TNP-ATP in solution, it is difficult to detect the TNP-ATP that is displaced from the His6 loop by the competing nucleotides. Titrations of the TNP-ATP/His6 loop solution with buffer were made to determine the fluorescence changes caused by dilution. Subtraction of the dilution effect from the nucleotide titration experiments revealed the fluorescence changes associated with the nucleotide-induced TNP-ATP displacement from the His6 loop.

Circular Dichroism Measurements-- CD spectra were taken on a JASCO J-500 A spectrophotometer. Measurements were made using a 0.1-mm path length cell (Helma) at a constant temperature of 20 °C. Data were collected on an IBM/PC-XT using the IF-2 interface; software was provided by Jasco. Spectra and buffer baselines were the average of 10 scans, each recorded at 0.1-nm intervals, using a scanning rate of 5 nm/min and a 2-s time constant. The protein concentration was determined by amino acid analysis and was approximately 2.0 mg/ml. Before spectral deconvolution for secondary structure analysis, the buffer baseline was subtracted and the resulting spectrum was smoothed using the program provided by Jasco. The secondary structure of the His6 loop was computed using the singular-value and variable-selection methods of Compton et al. (11).

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Our goal was to characterize the isolated ATP binding domain of the Na,K-ATPase. As a means to this end, we developed a method to produce large quantities of a soluble peptide corresponding to the cytoplasmic loop between transmembrane segments M4 and M5 (i.e. from Lys354 to Lys774, rat alpha 1 subunit).

Overexpression and Purification of the His6 alpha -Loop Fusion Protein-- The plasmid pAN was constructed by inserting the cDNA encoding the rat alpha 1 M4M5 cytoplasmic loop into pET-28 multiple cloning site at the ndeI (5') and the EcoRI (3') restriction site locations downstream from the histidine coding sequence (Fig. 1). pAN was used to transform a BL21(DE3) E. coli strain. For induction of gene expression, cells were grown in 1 liter of LBkan medium containing a final ethanol concentration of 2%, and fusion protein production was induced with IPTG. (The presence of ethanol significantly increased the amount of fusion protein in the soluble fraction.) This process routinely yielded significant production of the His6 loop fusion protein (molecular mass, ~46 kDa) with approximately 40% associated with the soluble fraction (Fig. 2). The His6 loop was purified via a Ni-NTA affinity column (~20-25 mg/liter; Fig. 2).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic representation of pAN construction for the expression of the His6 loop fusion protein. The pAN expression vector was constructed via a two step procedure. A cDNA fragment encoding the M4M5 cytoplasmic loop of the rat Na,K-ATPase alpha 1 subunit was obtained by PCR and initially inserted into the screening vector pCR-Script (Stratagene). The construct was excised from pCR-Script and cloned into pET-28 (Novagen).


View larger version (78K):
[in this window]
[in a new window]
 
Fig. 2.   SDS-polyacrylamide gel electrophoresis analysis of His6 loop expression and purification. A Laemmli gel showing His6 fusion protein production in E. coli BL21(DE3) cells. A single colony was grown overnight and used to inoculate 1L of LBkan. Protein synthesis was induced with 1 mM IPTG. Stds, molecular mass standards (kDs); Uninduced, 100 µl of uninduced whole cell growth pelleted and resuspended in Laemmli sample buffer; Induced, 100 µl of induced whole cell growth pelleted and resuspended in Laemmli sample buffer; Pellet, aliquot of pelleted fraction after cell lysis; Supernatant, aliquot of soluble fraction after cell lysis; Flow Through, aliquot of soluble fraction after being applied to Ni2+-NTA column; Eluate, His6 fusion protein eluted from the Ni2+-NTA column with imidazole.

FITC Labeling of the His6 Loop-- FITC is a fluorescent amine-reactive molecule that labels Lys501 in the purified Na,K-ATPase; this reaction is prevented by the simultaneous presence of ATP (12, 13). In this study, we used ATP protection against FITC labeling as a tool to demonstrate that ATP binds to His6 loop (Fig. 3A). It is clear that after incubation with 5 µM FITC, both the purified Na,K-ATPase and the His6 loop were labeled by FITC. Moreover, when the FITC incubation was performed in the presence of either 5 mM ATP or 5 mM AMP, only ATP (not AMP) prevented FITC modification of both the intact purified sodium pump and the His6 loop (Fig. 3A).


View larger version (101K):
[in this window]
[in a new window]
 
Fig. 3.   FITC labeling of purified dog Na,K-ATPase and His6 loop fusion protein. Both pictures are of the same Laemmli gel. The picture on the left was taken under UV illumination to show FITC fluorescence, and the picture on the right was taken after Coomassie Brilliant Blue R-250 staining. A 10-µg quantity of purified His6 loop was incubated with 5 µM FITC for 10 min at 25 °C in the absence (Ctl) or presence of 5 mM of the indicated nucleotide triphosphate. A, comparison of FITC labeling of native Na,K-ATPase and His6 loop. STDs, molecular mass standards; E, Ctl and L, Ctl, FITC only; E, ATP and L, ATP, FITC with 5 mM ATP; E, AMP and L, AMP, FITC and 5 mM AMP. Clearly, ATP prevents FITC labeling, whereas AMP is without effect. B, FITC labeling of the His6 loop in the presence of various nucleotides. Both ATP and ADP prevented FITC modification (E, ATP and E, AMP), whereas AMP, CTP, GTP, and UTP were without effect (L, Ctl, L, ATP, and L, AMP).

To further investigate the nucleotide specificity of the His6 loop, we tested the ability of several nucleotides to protect against FITC modification (Fig. 3B). Purified His6 loop was incubated with 5 µM FITC in the presence of 5 mM ATP, ADP, AMP, GTP, and UTP. It is clear that both ATP and ADP protected against FITC, whereas AMP, CTP, GTP, and UTP were unable to prevent FITC modification. These data are in agreement with the nucleotide specificity demonstrated for the purified Na,K-ATPase, which has been shown to bind ATP and ADP with high affinity, (14). Therefore, it appears that the His6 loop retains the structural parameters that confer nucleotide specificity in the intact enzyme.

Structural Analysis of the His6 Loop-- The structural integrity of the His6 loop was directly reflected by the structural requirement for FITC modification, i.e. after we denatured the His6 loop with 1% SDS, incubation with FITC failed to modify the peptide (Fig. 4). Similar results were observed when we denatured purified dog Na,K-ATPase with 1% SDS (Fig. 4). These results are not due to an anomalous effect of SDS on the FITC reaction; FITC was also unable to modify the His6 loop after denaturation with 6 M guanidine-HCl or by repeated freezing and thawing (data not shown).


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 4.   FITC labeling of intact and denatured His6 loop and purified dog Na,K-ATPase. Both pictures are of the same Laemmli gel. The picture on the left was taken under UV illumination to show FITC fluorescence, and the picture on the right was taken after Coomassie Brilliant Blue R-250 staining. A 10-µg quantity of purified dog Na,K-ATPase or His6 loop was incubated with 5 µM FITC for 10 min at 25 °C in the absence (Ctl) or presence (ATP) of 5 mM ATP. In addition, some samples (L, SDS, L, SDS, ATP, and E, SDS) were denatured with 1% SDS prior to FITC modification. STDs, molecular mass standards. It is evident that denaturation prevents FITC labeling of both the His6 loop and native Na,K-ATPase.

More directly, the overall secondary structure of the His6 loop fusion protein was estimated by CD spectroscopy. As shown in Fig. 5, the resultant spectrum, which summarizes the mean residue molar ellipticity as a function of wavelength, exhibits a maximum at 188 nm and two minima, one at 206 nm and the other at 221 nm. The spectrum is the average of 10 scans, the general shape of which did not change. Analysis of the CD spectrum of the His6 loop, calculated using the singular-value decomposition method (11), predicts secondary structural elements distributed approximately as 23% alpha -helix, 23% antiparallel beta -sheet, 4% parallel beta -sheet, 19% beta -turn, and 32% random coil. The total of the fractions in this method is not constrained to be 100%, but rather should lie between 95 and 105%. The observation that the components sum to close to 100% indicates that the fusion protein is highly structured as assessed by this technique.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 5.   Circular dichroism spectrum of the His6 loop fusion protein. CD spectrum of His6 loop in 50 mM sodium phosphate, pH = 7.9.

MIANS Labeling of the His6 Loop-- Recently, the fluorescent sulfhydryl reagent MIANS was shown to inactivate the dog kidney Na,K-ATPase by specifically labeling a cysteine residue in the M4M5 loop of the Na,K-ATPase (15). Both MIANS labeling and enzyme inactivation were prevented by the simultaneous presence of ATP.2 In this study, we tested whether ATP was able to protect against MIANS modification of the His6 loop. Indeed, ATP, but not AMP prevented MIANS labeling of the bacterially produced His6 loop (Fig. 6). However, unlike FITC, MIANS does label the denatured peptide, but ATP no longer protects against its modification (Fig. 6). The simplest explanation for a lack of ATP protection is that there is no longer significant structure to bind ATP.


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 6.   MIANS labeling of intact and denatured His6 loop. Both pictures are of the same Laemmli gel. The picture on the left was taken under UV illumination to show MIANS fluorescence, and the picture on the right was taken after Coomassie Brilliant Blue R-250 staining. A 10-µg quantity of purified His6 loop was incubated with 50 µM MIANS for 10 min at 25 °C in the absence (Ctl) or presence (ATP and AMP) of 5 mM ATP or AMP. In addition, some samples (SDS) were denatured with 1% SDS prior to the MIANS reaction. STDs, molecular mass standards. MIANS readily modified the His6 loop in the absence of nucleotides or in the presence of AMP, whereas ATP completely prevented modification. Unlike FITC (Fig. 5), MIANS covalently modified the denatured protein, and ATP was without effect under denaturing conditions.

TNP-ATP Binding to the His6 Loop and Competition with Nucleotides-- The interactions of the His6 loop and TNP-ATP were studied. This fluorescent ATP analog has been shown to bind with high affinity to the native Na,K-ATPase, as well as to other members of the P-type ATPase family (17-19). TNP-ATP is a useful fluorescent probe for studying the nucleotide binding site because its fluorescence changes significantly on binding. When an aliquot of His6 loop was added to a solution containing 5 µM TNP-ATP, it resulted in an enhancement of the TNP-ATP fluorescence consistent with TNP-ATP binding to the engineered protein (Fig. 7). The addition of ATP to a solution containing His6 loop and TNP-ATP resulted in a decrease in the fluorescent signal, as would be expected if ATP displaced TNP-ATP from the His6 loop (Fig. 7).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 7.   Recordings of the raw data for TNP-ATP fluorescence. Excitation and emission wavelengths were 410 and 545 nm, respectively. Lane 1, 5 µM TNP-ATP in 50 mM MOPS buffer (pH 7.5) alone. Lane 2, addition of purified His6 loop (final concentration, 10 µM). 20 data points were collected per second, and the average of all the points from each group were used in subsequent experiments. Lanes 3-5, increasing ATP concentrations (lane 3, 300 µM ATP; lane 4, 600 µM ATP; lane 5, 2000 µM ATP). There was a significant increase in the fluorescence intensity of TNP-ATP after the addition of protein, consistent with TNP-ATP binding to the His6 loop. Also, subsequent additions of ATP compete with bound TNP-ATP, causing a decrease in the fluorescence signal. These data are from a single experiment in which ATP decreased the TNP-ATP fluorescence by ~80%. Over the course of all our experiments, the maximal TNP-ATP fluorescence change ranged from 30 to 80% and was typically between 40 and 50%.

The apparent binding affinity of the His6 loop for TNP-ATP was determined by titrating small aliquots of TNP-ATP into a solution containing His6 loop. Plotting the fluorescence change against [TNP-ATP] showed that the binding of TNP-ATP to the His-tagged construct was composed of two parts: a saturable component and a nonsaturable component (Fig. 8A). Subtraction of the nonsaturable component from all the data revealed the fluorescence changes due to specific TNP-ATP binding (Fig. 8B). The apparent affinity of the His6 loop for TNP-ATP was ~3 µM (Table I).


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 8.   Nucleotide binding to the His6 loop fusion protein. The enhanced extrinsic fluorescence of TNP-ATP upon binding to the His6 loop was observed at 545 nm after excitation at 410 nm. TNP-ATP was added in increments to a 50 mM MOPS solution containing His6 loop (100 µg/ml, pH 7.5) and the fluorescence intensity measured after each addition. The data are expressed as the percentage of change in fluorescence intensity. The fluorescence signal in the absence of TNP-ATP (i.e. the His6 loop in MOPS buffer) and the contribution from free TNP-ATP were subtracted from all the data points. A, total change in fluorescence intensity as a function of [TNP-ATP]. Data were fit to the equation: % change = (a · [TNP-ATP]/b + [TNP-ATP]) + (c · [TNP-ATP] + d), where a = maximal fluorescence change, b = Kd app for TNP-ATP, c = slope of the nonsaturable binding component, and d = y intercept of the nonsaturable binding component. B, change in fluorescence due to specific binding of TNP-ATP. The nonsaturable linear component in A was subtracted from all the data points and replotted in B as a function of [TNP-ATP]. Data were fit to the equation: a · [TNP-ATP]/b + [TNP-ATP]. The mean ± S.E. for the Kd from three separate experiments are shown in Table I.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Apparent affinities of nucleotides for the purified His6 loop
Excitation and emission wavelengths were 410 and 545 nm, respectively. Experiments were performed as described under "Experimental Procedures." The Kd values were taken from at least three separate experiments identical to those shown in Figs. 8 and 9. In addition, the measurements were performed on at least three different His6 loop preparations for each nucleotide. Fluorescence measurements made in the absence of protein showed that nucleotides did not alter the free TNP-ATP fluorescence.

The apparent affinities for ATP, ADP, and AMP were determined from their ability to displace bound TNP-ATP from the His6 loop. For these experiments, a 10-fold molar excess of the His6 loop protein compared with TNP-ATP was used to ensure that all (i.e. >99%) of the TNP-ATP was bound and that the contribution from the nonsaturable TNP-ATP binding component was zero (20). The competition of TNP-ATP binding by nucleotides is evidenced by a decrease in fluorescence intensity upon the release of TNP-ATP from the His6 loop. A plot of [nucleotide] versus percentage of change in fluorescence from a typical experiment is shown in Fig. 9. The apparent Kd values for ATP and ADP were ~350 µM and ~550 µM, respectively (Table I). AMP showed no saturable binding in the concentration range examined. For each nucleotide, the binding experiments were performed on three separate preparations of His6 loop with comparable results.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 9.   Competition of TNP-ATP binding by adenine nucleotides. The fluorescence of His6 loop bound TNP-ATP was observed at 545 nm after excitation at 410 nm. Aliquots from concentrated solutions of either ATP (A), ADP (B), and AMP (C) were then added to mixture, and the fluorescence changes were monitored. The decrease in fluorescence due to dilution were subtracted from the data. The change in fluorescence due to nucleotide binding was plotted against the concentration of the corresponding nucleotide. Data were fit to the same equation as in Fig. 8B. The mean ± S.E. for the Kd from three separate experiments are shown in Table I. Measurements were also made in the absence of protein, and no effects of the nucleotides were observed on the free TNP-ATP fluorescence.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

We have produced a soluble polypeptide by bacterial overexpression that is identical in sequence with the central loop of the rat alpha 1-subunit. We have shown that the peptide binds ATP and ADP, but not other nucleoside triphosphates, with the same specificity as native Na,K-ATPase. This highly ordered peptide also shows labeling and protection reactions characteristic of the intact Na,K-ATPase.

Chemical modification experiments (4, 2) of the Na,K-ATPase, as well as site-directed mutagenesis studies (1), suggest that several amino acids located between the fourth and fifth putative transmembrane segments participate in the coordination of ATP. However, in some instances, the data generated from these two methods appear to be contradictory. For example, labeling Lys501 with a number of reagents (e.g. FITC, SITS, and N-(2-nitro-4-isothiocyanophenyl)-imidazole) completely inactivates the enzyme; the prior binding of ATP prevents both modification and inactivation, consistent with Lys501 playing a role in ATP binding. However, when Lys501 was changed to methionine via site-directed mutagenesis (21), the enzyme retained activity, demonstrating that Lys501 is not essential for enzyme activity. How could Lys501 participate in ATP binding and yet not be required for enzyme activity? It is possible that Lys501 is one of several residues that form the ATP binding pocket. Loss of a single contact residue might result in a lower ATP affinity, but not in a loss of ATP binding. Therefore, in the presence of saturating ATP, Na,K-ATPase activity might remain normal. However, attaching a chemical reagent to a contact residue or a nearby residue not only removes that residue from coordination but also occupies space in the vicinity of that residue; thus, modification of Lys501 may prevent ATP binding via steric factors. Consequently, it is becoming readily apparent that a detailed three-dimensional structure is needed to conclusively identify the contact sites for ATP and to adequately describe its binding pocket.

To approach such experiments, the major cytoplasmic domain between M4 and M5 of the Na,K-ATPase was overexpressed in E. coli. Similar approaches have been employed by other laboratories to isolate the ATP binding domains of the yeast proton pump (22), the sarcoplasmic reticulum calcium pump (23), the sodium pump (24), and the cystic fibrosis transmembrane conductance regulator (25). The cDNA from the rat alpha 1 subunit, encoding 420 amino acids from Lys354-Lys774, was cloned into a fusion protein vector (His6 tag, pET-28) and transformed into E. coli. This method routinely yields approximately 20 mg of pure soluble peptide per liter of cell culture. We demonstrated that this expressed and purified peptide 1) retains an ordered structure, 2) can be labeled by both FITC and MIANS, 3) binds both ATP and ADP, and 4) binds the fluorescent ATP analog, TNP-ATP. Experiments are currently under way to crystalize the His6 loop.

Structural Analysis of the His6 Loop-- Detailed structural topology of the sodium pump awaits three-dimensional x-ray crystallographic analysis. However, some assessments have been made that suggest an alpha -subunit structure with 10 transmembrane segments. Also, all the residues associated with ATP binding have been localized to the major cytoplasmic loop between transmembrane segments M4 and M5 (2). Furthermore, the residues thus far implicated in nucleotide binding among all the members of the P-type ATPase family have been assigned to this cytosolic domain. Structural models of the nucleotide binding pocket of P-type ATPases have been proposed based upon sequence homology with different kinases (e.g. adenylate kinase and phosphoglycerate kinase; see Ref. 26). According to these models, the large cytoplasmic loop is divided into three domains: a phosphorylation domain, a nucleotide binding domain, and a central domain. We calculated the alpha -helix and beta -sheet content of the nucleotide binding domain portion (Arg524-Ile654) of the sheep Na,K-ATPase cytoplasmic loop from the data previously reported (26). According to their predictions using the method of Chou and Fasman (27), we obtained a composition of about 35% alpha -helix and 22.5% beta -sheet. These values agree reasonably well with our current findings of 23% alpha -helix and 27% beta -sheet for the secondary structure of the bacterially expressed M4M5 loop. The difference in alpha -helical content may suggest that the phosphorylation domain and the central domain (included in our analysis and not in that of Taylor and Green (26)) have significantly less helical structure than does the nucleotide binding domain. Alternatively, it may simply reflect the difference between CD analysis (this study) and primary structure comparison (26) or a less than completely retained structure of our His6 loop compared with native intact Na,K-ATPase.

Nucleotide Protection against Chemical Modification of the His6 Loop-- For almost two decades, it has been known that FITC irreversibly inhibits the Na,K-ATPase in an ATP-protectable manner (28). The site of FITC modification was identified as Lys501 (12, 13). Considerable evidence suggests that Lys501 resides in the ATP binding site of the sodium pump; this evidence includes the following: 1) ATP prevents modification of Lys501 (28), 2) the reactivity of Lys501 is sensitive to cation binding in a way similar to the effect that cation occupancy has on direct ATP binding (29-31; 15), and 3) an equivalent lysine residue exists in a conserved sequence among most members of the P-type II ATPase family (3).

In a fashion similar to the intact Na,K-ATPase, ATP and ADP (but not AMP) protect against FITC modification of our purified His6 loop (Fig. 3). Moreover, nucleotides that do not bind with high affinity to the native enzyme also do not protect the His6 loop from FITC modification (Fig. 3). These findings demonstrate that the His6 loop has folded sufficiently to allow formation of a nucleotide binding pocket that shows selectivity. Indeed, denaturing the His6 loop prior to FITC treatment results in no FITC labeling; the same finding was observed with the native Na,K-ATPase (Fig. 4). Thus, it appears that the selective reactivity of Lys501 toward FITC is a product of the special environment in the folded central loop. The appropriate folding of this ATP binding loop generates a highly reactive lysine at position 501. This is in contrast with the behavior of MIANS and Cys577 (see below).

We have observed that ATP, but not AMP, can also protect the loop against modification by the sulfhydryl reagent MIANS (Fig. 6). Recently, MIANS has been shown to modify a specific cysteine residue in the large cytoplasmic loop of purified Na,K-ATPase; ATP protects against MIANS modification. Proteolytic digestion and N-terminal amino acid sequencing has identified the MIANS-modified residue as either Cys549 or Cys577.2 ATP protection against modification at Lys501 and Cys577 (or Cys549) suggests that a compact folding of the loop may bring the distant segments of the peptide together. It is interesting, however, that after denaturation of this loop, modification still occurs with MIANS, but such modification is no longer affected by the simultaneous presence of ATP.

Nucleotide Binding Affinity-- The sodium pump and most other P-type ATPases have a complex ATP dependence; a high affinity ATP effect and a low affinity ATP effect. In the sodium pump, phosphorylation of E1 to E1~P requires Na, Mg and ATP. The Km value for Na-ATPase (Km for ATP <= 1 µM) agrees well with the measured ATP binding affinity (32, 33). At low ATP concentrations, the rate of hydrolysis is slow and limited by the release of potassium (34). However, higher ATP concentrations (Km(ATP) >=  100 µM) facilitate the deocclusion of potassium. This low affinity effect is seen as the Km for ATP under (Na + K)-ATPase conditions. ATP activation of the sodium pump, with both high and low apparent affinities, has been interpreted as being due to either two distinct ATP sites or to a single ATP binding region that alters its affinity in different pump conformations.

Using the fluorescent ATP analog, TNP-ATP, we were able to estimate the ATP affinity of the His6 loop. In experiments designed to determine the His6 loop affinity for TNP-ATP, we discovered that there were two components to the binding of this ATP analog, a saturable and nonsaturable component. Hellen and Pratap (20) reported a similar two-component binding curve for TNP-ATP binding to the native Na,K-ATPase. Subtracting the nonspecific binding from the data, revealed a specific saturable component with an apparent Kd of ~3 µM for TNP-ATP (Fig. 8B; Table I). This value is about an order of magnitude higher than the Na,K-ATPase binding affinity for TNP-ATP (~0.5 µM at 25 °C; Ref. 17), i.e. it appears to represent a low affinity site.

An affinity of 300-400 µM was found for ATP by competition and displacement of TNP-ATP (Table I). This value is in reasonable agreement with the low ATP affinity for the E2(K2) state of the native Na,K-ATPase associated with potassium deocclusion. In addition, the expressed domain has a similar affinity (Kd 500-600 µM; Table I) for ADP. This is consistent with the observation that in the low affinity E2-state of the sodium pump, ADP has been shown to facilitate potassium deocclusion and transport (16, 35-36). AMP concentrations up to 3 mM were not sufficient to displace TNP-ATP (Fig. 9C), and concentrations of up to 5 mM were unable to protect against FITC modification (Fig. 3).

Recently, the nucleotide binding domains of the sarcoplasmic reticulum calcium pump (23), the yeast proton pump (22), and the sodium pump (24) have been expressed in E. coli. In the sodium pump-expressed domain, ATP binding was demonstrated by measuring MgATP protection against photolabeling with 2-N3-ATP32; however, Mg alone appeared to protect as well as MgATP (24). All our experiments were performed in the absence of magnesium; thus, the effects are solely due to the nucleotides themselves. ATP binding to expressed loops from the proton pump and sarcoplasmic reticulum calcium pump was estimated by ATP competition of TNP-ATP, as in this study. The affinities for TNP-ATP binding to the calcium pump and proton pump domains were 2 and 6 µM, respectively, similar to our value of ~3 µM for the sodium pump domain. In contrast, the ATP affinity reported for the proton pump domain was ~3 mM (22), significantly different from that reported for the calcium pump domain (~200 µM; Ref. 23) and here for the sodium pump domain (~300 µM; Table I). The considerably lower affinity for the proton pump ATP binding domain may be due to an inherent property of the domain or possibly because the proton pump construct was a glutathione S-transferase fusion protein, whereas the calcium pump and sodium pump constructs were both His-tagged proteins. Indeed, we were unable to successfully measure the ATP affinity for the glutathione S-transferase version of our construct even though we were able to demonstrate that ATP protected against FITC modification. It turned out that ATP (5 mM) also protected against FITC labeling of glutathione S-transferase alone.3

It appears, then, that expression of the isolated central loops of these P-type ATPases produces a protein that is able to selectively bind ATP (or ADP) but with an affinity close to that seen in E2 forms. Because the isolated loop has considerable secondary structure, it seems reasonable to suppose that the high affinity binding form is generated by interactions with other parts of the ATPase (probably the cation binding domains). One way of modeling these changes in the ATP binding site would be to suppose that there are two states or forms, an R (relaxed) form and a T (tense) form, the R form having lower affinity for ATP and the T form, higher affinity (<1 µM). The changes in structure of the intact protein that we identify as E1 (high sodium affinity and high ATP affinity) and E2 (high potassium affinity and low ATP affinity) are mirrored by changes in T and R forms, respectively, in the ATP binding loop. It is interactions between the ATP binding domain in the loop and other segments of the protein that hold the loop in the tense form, which has a high affinity for ATP. In isolation, the loop is not constrained by these interactions, and a relaxed (R) form exists with low substrate affinity.

The present study of ATP binding to the purified M4M5 loop of the Na,K-ATPase provides a basis for future mutagenesis studies of the residues thought to play a role in ATP binding. Furthermore, the ability to obtain large quantities of pure soluble protein makes this method valuable for detailed structural analyses of the wild-type and mutant ATP binding domains of P-type ATPases.

    ACKNOWLEDGEMENTS

We are grateful to Sylvia Daoud, Jeremy Holden, and Jeremy Johnston for excellent technical assistance. In addition, we thank Dr. Linda Kenney for insight and advice during the cloning of both the glutathione S-transferase and His6-tagged fusion proteins. We thank Dr. David Farrens for helpful suggestions with the fluorometry experiments and Dr. Susan Thornewell for helpful comments throughout this work. Dr. Hans Peter Bachinger is gratefully acknowledged for help, both practical and intellectual, with the CD measurements and interpretation.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant HL 30315 (to J. H. K.) and by an American Heart Association (Oregon Affiliate) fellowship (to C. G.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, L224, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd., Portland, OR 97201-3098. Tel.: 503-494-1001; Fax: 503-494-1002; E-mail: kaplanj{at}ohsu.edu.

1 The abbreviations used are: FITC, fluorescein 5'-isothiocyanate; TNP-ATP, 2',3'-O-[2,4,6,-trinitrophenyl]adenosine 5'-triphosphate; MIANS, 2-[4'maleimidylanilino]napthalene-6-sulfonic acid; IPTG, isopropyl beta -D-thiogalactoside; MOPS, morpholinepropanesulfuric acid; LB, Luria broth; PCR, polymerase chain reaction; SDS, sodium dodecyl sulfate; His6 loop, 6-histidine-tagged M4M5 cytoplasmic loop from the rat Na,K-ATPase alpha 1-subunit; CAPS, 3-(cyclohexylamino)propanesulfonic acid; SITS, 4-acetamido-4'-isothiocyanostilbene-2,2'-disulfonic acid.

2 S. J. Thornewell, J. P. Holden, and J. H. Kaplan, manuscript in preparation.

3 C. Gatto, L. J. Kenney, and J. H. Kaplan, unpublished data.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Lingrel, J. B, and Kuntzweiler, T. (1994) J. Biol. Chem. 269, 19659-19662[Free Full Text]
  2. Kaplan, J. H. (1991) in The Sodium Pump: Structure, Mechanism, and Regulation (Kaplan, J. H., and De Weer, P., eds), pp. 117-128, The Rockefeller University Press, New York
  3. Lutsenko, S., and Kaplan, J. H. (1995) Biochemistry 34, 15607-15613[Medline] [Order article via Infotrieve]
  4. Pedemonte, C. H., and Kaplan, J. H. (1990) Am. J. Physiol. 258, C1-C23[Abstract/Free Full Text]
  5. Johnson, C. L., Kuntzweiler, T. A., Lingrel, J. B, Johnson, C. G., and Wallick, E. T. (1995) Biochem. J. 309, 187-194[Medline] [Order article via Infotrieve]
  6. Pedersen, P. A., Rasmussen, J. H., and Jorgensen, P. L. (1996) J. Biol. Chem. 271, 2514-2522[Abstract/Free Full Text]
  7. Kaplan, J. H., Lutsenko, S., Gatto, C., Daoud, S., and Kenney, L. J. (1997) Ann. N. Y. Acad. Sci. 834, 45-55[Medline] [Order article via Infotrieve]
  8. Maniatis, T., Fritsch, E., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual, pp. 1.82-1.84, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  9. Bradford, M. M. (1976) Anal. Biochem. 72, 248-252[CrossRef][Medline] [Order article via Infotrieve]
  10. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
  11. Compton, L. A., Mathews, C. K., and Johnson, W. C., Jr. (1987) J. Biol. Chem. 262, 13039-13043[Abstract/Free Full Text]
  12. Farley, R. A., Tran, M. C., Carilli, C. T., Hawke, D., and Shively, J. E. (1984) J. Biol. Chem. 259, 9532-9535[Abstract/Free Full Text]
  13. Kirley, T. L., Wallick, E. T., and Lane, L. K. (1984) Biochem. Biophys. Res. Commun. 125, 767-773[Medline] [Order article via Infotrieve]
  14. Jensen, J., and Norby, J. G. (1971) Biochem. Biophys. Acta 233, 395-403[Medline] [Order article via Infotrieve]
  15. Kaplan, J. H., Gatto, C., Holden, J. P., and Thornewell, S. J. (1998) Acta. Scand. Physiol., in press
  16. Forbush, B., III (1987) J. Biol. Chem. 262, 11104-11115[Abstract/Free Full Text]
  17. Moczydlowski, E. G., and Fortes, P. A. G. (1981) J. Biol. Chem. 256, 2346-2356[Abstract/Free Full Text]
  18. Moczydlowski, E. G., and Fortes, P. A. G. (1981) J. Biol. Chem. 256, 2357-2366[Abstract/Free Full Text]
  19. Dupont, Y., Chapron, Y., and Pougeuis, R. (1982) Biochem. Biophys. Res. Commun. 106, 1272-1279[Medline] [Order article via Infotrieve]
  20. Hellen, E. H., and Pratap, P. R. (1997) Ann. N. Y. Acad. Sci. 834, 439-441[Medline] [Order article via Infotrieve]
  21. Ohtsubo, M., Noguchi, S., Takeda, K., Morohashi, M., and Kawamura, M. (1990) Biochim. Biophys. Acta. 1021, 157-160[Medline] [Order article via Infotrieve]
  22. Capieaux, E., Rapin, C., Thines, D., Dupont, Y., and Goffeau, A. (1993) J. Biol. Chem. 268, 21895-21900[Abstract/Free Full Text]
  23. Moutin, M.-J., Cuillel, M., Rapin, C., Miras, R., Anger, M., Lompre, A.-M., and Dupont, Y. (1993) J. Biol. Chem. 269, 11147-11154[Abstract/Free Full Text]
  24. Tran, C. M., Hrouda, E., Grisham, C. M., and Farley, R. A. (1996) Biophys. J. 70, A329
  25. Ko, Y. H., Thomas, P. J., Delannoy, M. R., and Pedersen, P. L. (1993) J. Biol. Chem. 268, 24330-24338[Abstract/Free Full Text]
  26. Taylor, W. R., and Green, K. M. (1989) Eur. J. Biochem. 179, 241-248[Abstract]
  27. Chou, P. Y., and Fasman, G. D. (1974) Biochemistry 13, 212-245
  28. Karlish, S. J. D. (1980) J. Bioenerg. Biomembr. 12, 111-136[Medline] [Order article via Infotrieve]
  29. Pedemonte, C. H., and Kaplan, J. H. (1988) Biochemistry 27, 7966-7973[Medline] [Order article via Infotrieve]
  30. Ellis-Davies, G. C. R., and Kaplan, J. H. (1990) J. Biol. Chem. 265, 20570-20576[Abstract/Free Full Text]
  31. Gatto, C., Lutsenko, S., and Kaplan, J. H. (1997) Arch. Biochem. Biophys. 340, 90-100[CrossRef][Medline] [Order article via Infotrieve]
  32. Jensen, J., and Norby, J. G. (1971) Biochem. Biophys. Acta 233, 104-116[Medline] [Order article via Infotrieve]
  33. Hegyvary, C., and Post, R. L. (1971) J. Biol. Chem. 246, 5234-5240[Abstract/Free Full Text]
  34. Post, R. L., Hegyvary, C., and Kume, S. (1972) J. Biol. Chem. 247, 6530-6540[Abstract/Free Full Text]
  35. Glynn, I. M., and Richards, D. E. (1982) J. Physiol. 218, 239-256[Medline] [Order article via Infotrieve]
  36. Kaplan, J. H., and Kenney, L. J. (1982) Ann. N. Y. Acad. Sci. 402, 292-295[Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.